Naggie, S., Osinusi, A., Himmel, T., Lucas, J., Thompson, J. W., Dubois, L. G., … Patel, K. (2012). Targeted proteomics signature identifies corticosteroid binding globulin peptides as highly predictive of treatment response in IL28B unfavorable genotype patients. In HEPATOLOGY (Vol. 56, pp. 999A-1000A). Boston, MA: WILEY-BLACKWELL.

Naggie, Susanna, Anu Osinusi, Tiffany Himmel, Joseph Lucas, J. W. Thompson, Laura G. Dubois, Martin A. Moseley, Paul J. Clark, Shyam Kottilil, and Keyur Patel. “Targeted proteomics signature identifies corticosteroid binding globulin peptides as highly predictive of treatment response in IL28B unfavorable genotype patients.” In HEPATOLOGY, 56:999A-1000A. WILEY-BLACKWELL, 2012.

Naggie S, Osinusi A, Himmel T, Lucas J, Thompson JW, Dubois LG, et al. Targeted proteomics signature identifies corticosteroid binding globulin peptides as highly predictive of treatment response in IL28B unfavorable genotype patients. In: HEPATOLOGY. WILEY-BLACKWELL; 2012. p. 999A-1000A.

Naggie, Susanna, et al. “Targeted proteomics signature identifies corticosteroid binding globulin peptides as highly predictive of treatment response in IL28B unfavorable genotype patients.” HEPATOLOGY, vol. 56, WILEY-BLACKWELL, 2012, pp. 999A-1000A.

Naggie S, Osinusi A, Himmel T, Lucas J, Thompson JW, Dubois LG, Moseley MA, Clark PJ, Kottilil S, Patel K. Targeted proteomics signature identifies corticosteroid binding globulin peptides as highly predictive of treatment response in IL28B unfavorable genotype patients. HEPATOLOGY. WILEY-BLACKWELL; 2012. p. 999A-1000A.